Macromastia: an economic burden? A disease cost analysis based on real-world data in Germany.
Sebastian M JudAnne Brendle-BehnischCarolin C HackCaroline PreussAndreas ArkudasRaymund E HorchMatthias W BeckmannMichael P LuxPublished in: Archives of gynecology and obstetrics (2020)
These results show that considerable health-care costs arise due to macromastia with conservative treatment. Overall, macromastia costs €1677.55 per patient/year. In particular, lost productivity due to sick days and the costs of physiotherapy are factors driving the high costs.